A new study analyzed the prevalence of cannabis vaping, cases of e-cigarette or vaping product-use-associated lung injury (EVALI), and marijuana laws in 13 states.
Researchers used data from the 2019 Behavioral Risk Factor Surveillance System (BRFSS) and the Centers for Disease Control and Prevention (CDC). BRFSS noted that "while more people reported vaping marijuana in states that have legalized it for medical or recreational use, that prevalence didn’t translate into a greater percentage of EVALI case burdens compared to non-legal states."
